PubRank

Hobyung Chung

Author PubWeight™ 53.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 2003 2.87
2 Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score. Hepatology 2004 2.66
3 Low-dose, long-term, intermittent interferon-alpha-2b therapy after radical treatment by radiofrequency ablation delays clinical recurrence in patients with hepatitis C virus-related hepatocellular carcinoma. Intervirology 2005 1.33
4 Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 2008 1.28
5 Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. AJR Am J Roentgenol 2004 1.20
6 Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. AJR Am J Roentgenol 2004 1.17
7 Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 2007 1.17
8 Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003 1.15
9 Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003 1.13
10 Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation. AJR Am J Roentgenol 2008 1.12
11 Hepatic arterial infusion chemotherapy using low-dose 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma. Oncology 2010 1.08
12 Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT. J Gastroenterol 2012 1.06
13 Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography. Oncology 2008 1.03
14 Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography. Intervirology 2008 1.03
15 Des-γ-carboxyprothrombin may be a promising biomarker to determine the therapeutic efficacy of sorafenib for hepatocellular carcinoma. Dig Dis 2011 1.03
16 Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma. J Gastroenterol 2007 1.01
17 Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience. Liver Int 2010 1.01
18 Percutaneous ultrasound-guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. J Gastroenterol 2003 1.00
19 Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images. Oncology 2007 0.99
20 Regulatory failure of serum prohepcidin levels in patients with hepatitis C. Hepatol Res 2006 0.96
21 Hepatocellular carcinoma mimicking cavernous hemangioma on angiography and contrast enhanced harmonic ultrasonography. A case report. Hepatol Res 2003 0.96
22 Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study. Oncology 2007 0.95
23 Clinical characteristics of NonBNonC- HCC: Comparison with HBV and HCV related HCC. Intervirology 2006 0.92
24 Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis. Dig Dis 2011 0.92
25 Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. AJR Am J Roentgenol 2004 0.91
26 Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC. J Hepatol 2008 0.91
27 Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images. Oncology 2008 0.90
28 PIVKA-II is the best prognostic predictor in patients with hepatocellular carcinoma after radiofrequency ablation therapy. Oncology 2008 0.90
29 Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. AJR Am J Roentgenol 2007 0.90
30 Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation. Dig Dis 2007 0.89
31 Non-invasive evaluation of hepatic fibrosis for type C chronic hepatitis. Intervirology 2010 0.88
32 Combination therapy with S-1 and pegylated interferon alpha for advanced hepatocellular carcinoma. Oncology 2008 0.88
33 Intrahepatic huge hematoma due to rupture of small hepatocellular adenoma: a case report. Hepatol Res 2002 0.87
34 The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma. J Gastroenterol 2010 0.86
35 A new prognostic staging system for hepatocellular carcinoma: value of the biomarker combined Japan integrated staging score. Intervirology 2008 0.85
36 Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult cases. Oncology 2010 0.84
37 Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography. Oncology 2011 0.83
38 Percutaneous aspiration and ethanolamine oleate sclerotherapy for sustained resolution of symptomatic polycystic liver disease: an initial experience. AJR Am J Roentgenol 2009 0.83
39 Elevated serum ALT levels during pegylated interferon monotherapy may be caused by hepatic iron overload. Intervirology 2008 0.82
40 Case of rapidly progressed sarcomatoid hepatocellular carcinoma in a young female without risk factor. Liver Int 2007 0.82
41 Intracystic hemorrhage in a patient of polycystic kidney with renocolic fistula diagnosed by contrast-enhanced ultrasonography. Intern Med 2008 0.81
42 Activation of c-Jun N-terminal kinase in non-cancerous liver tissue predicts a high risk of recurrence after hepatic resection for hepatocellular carcinoma. Hepatol Res 2012 0.81
43 The gross classification of hepatocellular carcinoma: usefulness of contrast-enhanced US. J Clin Ultrasound 2014 0.81
44 Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images. J Gastroenterol 2005 0.81
45 Hepatic angiomyolipoma: identification of an efferent vessel as a hepatic vein by contrast-enhanced harmonic sonography. J Med Ultrason (2001) 2005 0.80
46 Hepatobiliary and pancreatic: arterioportal fistula causing portal hypertension. J Gastroenterol Hepatol 2003 0.80
47 Tumor markers after radiofrequency ablation therapy for hepatocellular carcinoma. Hepatogastroenterology 2008 0.79
48 What is the best time to evaluate treatment response after radiofrequency ablation of hepatocellular carcinoma using contrast-enhanced sonography? Oncology 2007 0.79
49 Usefulness of the post-vascular phase of contrast-enhanced ultrasonography with sonazoid in the evaluation of gross types of hepatocellular carcinoma. Oncology 2010 0.79
50 Transient portal vein thrombosis caused by radiofrequency ablation for hepatocellular carcinoma. J Gastroenterol 2003 0.79
51 Single HCC between 2 and 5 cm: the grey zone: hepatologist's perspective. J Hepatobiliary Pancreat Sci 2009 0.79
52 Long-term follow-up of atypical progressive focal nodular hyperplasia increasing in size and number implicates its pathogenesis. Am J Gastroenterol 2008 0.78
53 Contrast-enhanced ultrasound techniques for guiding and assessing response to locoregional treatments for hepatocellular carcinoma. Oncology 2010 0.78
54 Prolonged PEG-IFN and RBV is effective in patients with HCV genotype 1 and high viral load who achieved virological response later than 24 weeks. Intervirology 2010 0.77
55 Stage IV hepatocellular carcinoma with portal venous tumor thrombus: complete response after combined therapy of repeated arterial chemoembolization and radiofrequency ablation. J Gastroenterol 2003 0.77
56 Association of interleukin-28B and hepatitis C genotype 1 with a high viral load and response to pegylated interferon plus ribavirin therapy. Digestion 2011 0.77
57 Autoimmune hepatitis and immunoglobulin G4-associated autoimmune hepatitis. Dig Dis 2013 0.77
58 Clinical significance of the genotype and core promoter/pre-core mutations in hepatitis B virus carriers. Intervirology 2006 0.76
59 [A case of jejunal ectopic pancreatic cancer: the diagnostic usefulness of MRI]. Nihon Shokakibyo Gakkai Zasshi 2015 0.75
60 Outcomes and Prognostic Factors in Patients with Spontaneously Ruptured Hepatocellular Carcinoma. Hepatogastroenterology 2015 0.75
61 PEG-IFNalpha/RBV combination therapy for chronic hepatitis C patients increases serum ferritin level while it improves sustained viral response rate. Intervirology 2010 0.75
62 Hepatocellular carcinoma that ruptured during radiofrequency ablation therapy. J Gastroenterol 2004 0.75
63 [Effects of interferon treatment on recurrence and survival after curative treatment of hepatitis C virus-related hepatocellular carcinoma]. Nihon Rinsho 2011 0.75
64 Foreign body granuloma mimicking disseminated tumour recurrence after radiofrequency ablation for hepatocellular carcinoma. Liver Int 2008 0.75
65 [Comparison of treatment methods for hepatocellular carcinoma--based on JIS score]. Gan To Kagaku Ryoho 2004 0.75
66 Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C. Dig Dis 2017 0.75
67 CD68-Positive Cells in Hepatic Angiomyolipoma. Oncology 2016 0.75